WJA
AGIO icon

Williams Jones & Associates’s Agios Pharmaceuticals AGIO Stock Holding History

Williams Jones & Associates’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,020
Closed -$488K – 397
2016
Q1 		$488K Sell
12,020
-8,907
-43% -$381K 0.02% 208
2015
Q4 		$1.36M Sell
20,927
-6,933
-25% -$455K 0.06% 148
2015
Q3 		$1.97M Sell
27,860
-4,065
-13% -$397K 0.09% 142
2015
Q2 		$3.55M Sell
31,925
-3,485
-10% -$375K 0.14% 127
2015
Q1 		$3.34M Sell
35,410
-2,275
-6% -$255K 0.13% 130
2014
Q4 		$4.22M Buy
37,685
+10
+0% +$893 0.17% 115
2014
Q3 		$2.31M Buy
37,675
+20,375
+118% +$878K 0.11% 120
2014
Q2 		$793K Sell
17,300
-8,420
-33% -$343K 0.04% 187
2014
Q1 		$1.01M Buy
25,720
+15,470
+151% +$518K 0.02% 241
2013
Q4 		$245K Buy
+10,250
New +$234K 0.01% 262

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return